André, S., Verteneuil, S., Ris, L., Kahvecioglu, Z.-C., Nonclercq, D., De Winter, J., Vander Elst, L., Laurent, S., Muller, R. N., & Burtea, C. (29 December 2023). Modulation of Cytosolic Phospholipase A2 as a Potential Therapeutic Strategy for Alzheimer's Disease. Journal of Alzheimer's Disease Reports, 7 (1), 1395 - 1426. doi:10.3233/ADR-230075 |
D'Aes, T., Marlier, Q., Verteneuil, S., Quatresooz, P., Vandenbosch, R.* , & Malgrange, B.*. (10 April 2023). Re-Evaluating the Relevance of the Oxygen-Glucose Deprivation Model in Ischemic Stroke: The Example of Cdk Inhibition. International Journal of Molecular Sciences, 24 (8), 7009. doi:10.3390/ijms24087009 * These authors have contributed equally to this work. |
André, S., Larbanoix, L., Verteneuil, S., Stanicki, D., Nonclercq, D., Vander Elst, L., Laurent, S., Muller, R., & Burtea, C. (2020). Development of an LDL Receptor-Targeted Peptide Susceptible to Facilitate the Brain Access of Diagnostic or Therapeutic Agents. Biology. doi:10.3390/biology9070161 |
Marlier, Q., Verteneuil, S., Vandenbosch, R., & Malgrange, B. (2015). Mechanisms and Functional Significance of Stroke-Induced Neurogenesis. Frontiers in Neuroscience. doi:10.3389/fnins.2015.00458 |